MGMT and glioblastoma: This novel compound exhibits high BBB permeability, preferentially accumulates in orthotopic GBM models with minimal off-target toxicity, and circumvents O6-methylguanine-DNA methyltransferase (MGMT)-mediated resistance through dual mechanisms of DNA crosslinking and alkylation [200].